Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;17(8):707-718.
doi: 10.1111/crj.13606. Epub 2023 Mar 21.

A pooled analysis of the risk prediction models for mortality in acute exacerbation of chronic obstructive pulmonary disease

Zile Ji  1   2 , Xuanlin Li  1   2 , Siyuan Lei  1   2 , Jiaxin Xu  1   2 , Yang Xie  1   2
Affiliations
Review

A pooled analysis of the risk prediction models for mortality in acute exacerbation of chronic obstructive pulmonary disease

Zile Ji et al. Clin Respir J. 2023 Aug.

Abstract

Objective: The prognosis for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is not optimistic, and severe AECOPD leads to an increased risk of mortality. Prediction models help distinguish between high- and low-risk groups. At present, many prediction models have been established and validated, which need to be systematically reviewed to screen out more suitable models that can be used in the clinic and provide evidence for future research.

Methods: We searched PubMed, EMBASE, Cochrane Library and Web of Science databases for studies on risk models for AECOPD mortality from their inception to 10 April 2022. The risk of bias was assessed using the prediction model risk of bias assessment tool (PROBAST). Stata software (version 16) was used to synthesize the C-statistics for each model.

Results: A total of 37 studies were included. The development of risk prediction models for mortality in patients with AECOPD was described in 26 articles, in which the most common predictors were age (n = 17), dyspnea grade (n = 11), altered mental status (n = 8), pneumonia (n = 6) and blood urea nitrogen (BUN, n = 6). The remaining 11 articles only externally validated existing models. All 37 studies were evaluated at a high risk of bias using PROBAST. We performed a meta-analysis of five models included in 15 studies. DECAF (dyspnoea, eosinopenia, consolidation, acidemia and atrial fibrillation) performed well in predicting in-hospital death [C-statistic = 0.91, 95% confidence interval (CI): 0.83, 0.98] and 90-day death [C-statistic = 0.76, 95% CI: 0.69, 0.82] and CURB-65 (confusion, urea, respiratory rate, blood pressure and age) performed well in predicting 30-day death [C-statistic = 0.74, 95% CI: 0.70, 0.77].

Conclusions: This study provides information on the characteristics, performance and risk of bias of a risk model for AECOPD mortality. This pooled analysis of the present study suggests that the DECAF performs well in predicting in-hospital and 90-day deaths. Yet, external validation in different populations is still needed to prove this performance.

Keywords: AECOPD; mortality; pooled analysis; prediction models.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

FIGURE 1
FIGURE 1
Literature screening flow chart.
FIGURE 2
FIGURE 2
Predictors in 26 risk prediction models for AECOPD mortality. AECOPD, acute exacerbation of chronic obstructive pulmonary disease; BMI, body mass index; PaCO2, partial pressure of carbon dioxide.
FIGURE 3
FIGURE 3
Risk of bias assessment in 37 studies.
FIGURE 4
FIGURE 4
Forest plot showing C‐statistics of BAP‐65 scores in predicting in‐hospital, 30‐day, and 90‐day mortalities.
FIGURE 5
FIGURE 5
Forest plot showing C‐statistics of CURB‐65 scores in predicting in‐hospital, 30‐day, and 90‐day mortalities.
FIGURE 6
FIGURE 6
Forest plot showing C‐statistics of DECAF scores in predicting in‐hospital, 30‐day, and 90‐day mortalities.
FIGURE 7
FIGURE 7
Forest plot showing C‐statistics of NEWS scores in predicting in‐hospital mortality and CODEX scores in predicting 90‐day and 1‐year mortalities.
See this image and copyright information in PMC

References

    1. Global Initiative for Chronic Obstructive Lung Disease . (updated 2022). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Accessed April 23, 2022. https://goldcopd.org/2022-gold-reports-2/
    1. GBD Chronic Respiratory Disease Collaborators . Prevalence and attributable health burden of chronic respiratory diseases, 1990‐2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585‐596. doi:10.1016/S2213-2600(20)30105-3 - DOI - PMC - PubMed
    1. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786‐796. doi:10.1016/S0140-6736(07)61382-8 - DOI - PMC - PubMed
    1. Soler‐Cataluña JJ, Martínez‐García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925‐931. doi:10.1136/thx.2005.040527 - DOI - PMC - PubMed
    1. Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann am Thorac Soc. 2013;10(2):81‐89. doi:10.1513/AnnalsATS.201208-043OC - DOI - PubMed